Pertuzumab

Pertuzumab is a human monoclonal antibody directed against the human epidermal growth factor receptor 2 protein (HER2), a protein found on HER2-positive cancer cells. By attaching to HER2, pertuzumab inhibits HER2 producing signals that cause the cancer cells to grow.

What can Sanquin do for you?

Measure drug levels of free drug in the serum using an validated ELISA.
Measure the immunogenicity of Pertuzumab.
Provide assay reagents or co-develop novel testing strategies.
Folllowing ISO, FDA/EMA, RUO guidelines.

Enquire about our drug level and ADA assays by emailing us at [email protected].

Last edited on: 23 November 2022